About

“Innovation is seeing what everybody has seen and thinking what nobody has thought.”
— Dr. Albert Szent-Györgyi

Christine P. Bump

Christine P. Bump is an insightful regulatory attorney with 20 years of experience developing and implementing FDA strategies for cutting-edge medicine and technology. She advises CEOs, scientists, and teams of all levels on issues relating to devices, diagnostics, genetics and genomics, digital health, wellness, and advertising and promotion. Christine also counsels venture capital groups and portfolio companies on navigating the FDA process.

Christine works with a broad array of clients, from start-ups to large corporations, and is particularly astute at helping clients mitigate risks…

Christine P. Bump

Principal | Experienced Regulatory Attorney

LinkedIn

Why Choose Us

Novel Strategies for Novel Innovations.

Your innovations are focused and specific. While FDA law is frequently considered one practice area, it is comprised of several specialties. A counsel who understands this can help you chart your course.

A Niche Practice.

Penn Avenue Law & Policy is proud to focus on select areas of FDA law. Christine P. Bump’s experience is concentrated in six distinct Food and Drug law specialties.

Thorough. Attentive. Responsive.

When you become a client of Penn Avenue Law & Policy, you will receive timely, personal, and detailed attention. Your issues will be addressed thoroughly, with careful consideration of FDA’s requirements and your business and development goals.